CALL FOR APPLICATIONS
The “International Ph.D. Programme for Medical Doctors”, Emerald
Application deadline August 28th 2022, 5 pm Central European Time
- A medical doctor with up to four years of research experience?
- Eager to explore why diseases arise and to contribute to the development of novel treatments?
- Driven to pursue a Ph.D. and develop your scientific competencies?
Multiple Ph.D. positions are available for this call across seven top European biomedical research centers: BRIC (Copenhagen), CRG (Barcelona), NKI (Amsterdam), IGC (Lisbon) MDC (Berlin), VIB (Flanders), IC (Paris). In case of high numbers of exceptional good applications to this first call, up to 16 fellows will be hired. A second call will open in April 2022.
ABOUT THE PROGRAMME
The “International Ph.D. Programme for Medical Doctors”, Emerald, trains and nurtures excellent physician-scientists intending to bridge the gap between the clinic and the lab. The programme recruits medical doctors to carry out a Ph.D. in cutting-edge research in one of seven recruiting European centres of excellence in life sciences and biomedicine. The recruited medical doctors will acquire unique scientific, technical, and digital skills and knowledge to advance their careers at the frontier of medicine and research, with the final goal to improve patient care and tackle global health challenges.
Biomedical research is advancing at high speed. In the last decades, we have seen major developments resulting in significantly better treatment and healthcare. Addressing the increased need for innovative solutions in medicine requires more than ever the rise of the unique professional profile of physician-scientists, combining research with clinical care, understanding patients´ needs and driving research forward to address them.
ABOUT THE POSITIONS
The fellows will benefit from attractive salaries, an international, stimulating and creative environment with expert supervision, advanced training, tailored career development and mentoring programmes, and access to high-end technologies and facilities. They will have the opportunity to build valuable international networks with multiple actors in academia, hospitals, patients´ organizations and the private sector. Applicants have a genuine choice of laboratories in the seven recruiting institutions to apply to. Details for all the positions can be found here on the Emerald webpage: link.
ABOUT RECRUITING CENTERS
Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaløes Vej 5, DK-2200 Copenhagen N, Denmark; Positions at BRIC: link
Centre for Genomic Regulation (CRG), Dr. Aiguader 88, 08003 Barcelona, Spain; Positions at CRG: link
Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Positions at NKI: link
Instituto Gulbenkian de Ciência (IGC), Rua da Quinta Grande, 6, 2780-156 Oeiras, Portugal; Positions at IGC: link
Max Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany; Positions at MDC: link
The Flanders Institute for Biotechnology (VIB), Rijvisschestraat 120, 9052 Gent, Belgium; Positions at VIB: link
Institut Curie (IC), 26 rue d'Ulm, 75248 Paris cedex 05 , Paris, France; Positions at IC: link
Education: Candidates must have obtained a medical degree, which allows them to enroll in an official Doctoral programme following the national regulations and institutional requirements in force at each recruiting research center.
Years of research experience: At the date of the call deadline, candidates must be in the first four years of their research career (exceptions due to career break will be considered) and have not been awarded a Ph.D. degree.
Mobility: Candidates can be of any nationality, but must undertake trans-national mobility according to the H2020 MSCA programme´s rules. During the 3 years before the date of the call deadline, they must not have resided or carried out their main activity (work, studies, etc.) for more than 12 months in the country of the selected recruiting center for which they apply.
Language: English at an excellent level.
The selection process includes three steps of evaluation: Eligibility check, remote evaluation by expert panels, online interviews with the selection committee, on-site visit to the potential host institute and final selection. The selection will be merit-based, using weighted criteria in three defined areas:
- Candidate curriculum
- Knowledge and scientific potential
- English level
HOW TO APPLY?
The application deadline is the August 28th 2022, at 5 pm Central European Time.
Applications are accepted exclusively online through the online application system at the Emerald webpage: www.emerald-mdphd.eu. Late or incomplete applications will not be evaluated.
The application, in English, must include the following:
- Personal details, in line with the European Data Protection Law
- Degree information, including a copy of diploma and detailed transcripts of records (MSc and BSc)
- CV including:
- Scientific interests and record of accomplishments: publications (highlighting impact and contribution), research experience and main results, posters or talks at meetings, prizes, fellowships, etc.
- Outreach: technology transfer, science education and/or public engagement activities.
- Motivation letter (Cover letter), including an indication of preferred host laboratory/PI and research areas: maximum two laboratories of choice.
- Contacts of two referees.
- Eligibility statement
TERMS OF EMPLOYMENT AND SALARY
The Marie Skłodowska-Curie Actions offer attractive salaries and working conditions.
The positions are offered at seven research centers each in a different European country. National living costs and standards differ in those countries, which is reflected in the different gross salaries indicated in the table below.
The working contract will be for 42 months.
The salary and terms of employment are in accordance with the rules and regulations laid down by European Union’s Horizon 2020 Marie S. Curie COFUND programme.
Acknowledgment: Emerald has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101034290